Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph I Clark

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Clinical Advances in Hematology & Oncology : H&O|September 17, 2005
ReviewDaniel Farray, Joseph I Clark
Journal of Investigative Medicine High Impact Case Reports|August 22, 2025
Immunotherapy With Pembrolizumab for Resectable dMMR/MSI-H Stage III Colon Cancer: A Case of Personalized, Precision Surgery-Sparing ImmunotherapyStanley Kim, Joseph I Clark
Melanoma Management|September 8, 2018
Ipilimumab for the treatment of melanomaShikha Jain, Joseph I Clark
Cancer Chemotherapy and Pharmacology|July 15, 2009
A phase II study of oxaliplatin, docetaxel, and GM-CSF in patients with previously treated advanced melanomaFrederick Locke, Joseph I Clark, Thomas F Gajewski
Cancer Investigation|October 21, 2004
Case report and brief review: IL-2-induced myocarditisRobert M Eisner, Aliya Husain, Joseph I Clark
Current Treatment Options in Oncology|August 28, 2003
Nephrectomy in metastatic renal cell carcinomaSteven C Campbell, Robert C Flanigan, Joseph I Clark
Head & Neck|April 5, 2002
Response to paclitaxel and carboplatin in metastatic salivary gland cancer: a case reportJanet C Ruzich, Marlyn C Ciesla, Joseph I Clark
The Journal of Urology|February 9, 2021
Cytoreductive Nephrectomy for Synchronous Metastatic Renal Cell Carcinoma-Are There Any Favorable Risk Patients?Hiten D Patel, Joseph I Clark, Robert C Flanigan
Journal for Immunotherapy of Cancer|June 15, 2018
Rhabdomyolysis during high dose interleukin-2 treatment of metastatic melanoma after sequential immunotherapies: a case reportJoseph I Clark, Shams Bufalino, Shruti Singh, et al.
BMJ Case Reports|August 24, 2019
Combined radio-immunotherapy leads to complete clinical regression of stage IV Merkel cell carcinomaDaniel R Principe, Joseph I Clark, Bahman Emami, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Clinical Advances in Hematology & Oncology : H&O|September 17, 2005
ReviewDaniel Farray, Joseph I Clark
Journal of Investigative Medicine High Impact Case Reports|August 22, 2025
Immunotherapy With Pembrolizumab for Resectable dMMR/MSI-H Stage III Colon Cancer: A Case of Personalized, Precision Surgery-Sparing ImmunotherapyStanley Kim, Joseph I Clark
Melanoma Management|September 8, 2018
Ipilimumab for the treatment of melanomaShikha Jain, Joseph I Clark
Cancer Chemotherapy and Pharmacology|July 15, 2009
A phase II study of oxaliplatin, docetaxel, and GM-CSF in patients with previously treated advanced melanomaFrederick Locke, Joseph I Clark, Thomas F Gajewski
Cancer Investigation|October 21, 2004
Case report and brief review: IL-2-induced myocarditisRobert M Eisner, Aliya Husain, Joseph I Clark
Current Treatment Options in Oncology|August 28, 2003
Nephrectomy in metastatic renal cell carcinomaSteven C Campbell, Robert C Flanigan, Joseph I Clark
Head & Neck|April 5, 2002
Response to paclitaxel and carboplatin in metastatic salivary gland cancer: a case reportJanet C Ruzich, Marlyn C Ciesla, Joseph I Clark
The Journal of Urology|February 9, 2021
Cytoreductive Nephrectomy for Synchronous Metastatic Renal Cell Carcinoma-Are There Any Favorable Risk Patients?Hiten D Patel, Joseph I Clark, Robert C Flanigan
Journal for Immunotherapy of Cancer|June 15, 2018
Rhabdomyolysis during high dose interleukin-2 treatment of metastatic melanoma after sequential immunotherapies: a case reportJoseph I Clark, Shams Bufalino, Shruti Singh, et al.
BMJ Case Reports|August 24, 2019
Combined radio-immunotherapy leads to complete clinical regression of stage IV Merkel cell carcinomaDaniel R Principe, Joseph I Clark, Bahman Emami, et al.
Pageof 7